
What We're Reading: FDA Grants Priority Review for Amarin's Vascepa; HHS Rule Challenged; Military Mental Health Proposal
Amarin announced that its supplemental new drug application for Vascepa has been accepted for filing and granted Priority Review designation by the FDA; civil rights groups ask a federal court to strike down an HHS "conscience" rule that may limit services covered by providers and payers that violate religious or moral beliefs; US Representive Seth Moulton, D-Massachusetts, unveils a new military mental health proposal.
FDA Accepts sNDA for Amarin’s Vascepa, Grants Priority Review Designation
Amarin announced that its
Civil Rights Groups Ask a Federal Court to Strike Down HHS “Conscience” Rule
Lamba Legal and other civil rights groups have asked a federal court to strike down an HHS “conscience” rule that may create situations where healthcare providers, insurers, and other payers could refuse to cover services that they claim violate their religious or moral beliefs,
US Representative Unveils Military Mental Health Proposal
Representative Seth Moulton, D-Massachusetts, will introduce a plan Tuesday to expand military mental health services,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.